nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antitumor effect of the angiogenesis inhibitor TNP-470 on human digestive organ malignancy
|
Konno, Hiroyuki |
|
1999 |
43 |
1 |
p. S85-S89 |
artikel |
2 |
Biological implications of macrophage infiltration in human tumor angiogenesis
|
Ono, Mayumi |
|
1999 |
43 |
1 |
p. S69-S71 |
artikel |
3 |
Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice
|
Newman, Mary S. |
|
1999 |
43 |
1 |
p. 1-7 |
artikel |
4 |
Critical determinants of cancer metastasis: rationale for therapy
|
Fidler, Isaiah J. |
|
1999 |
43 |
1 |
p. S3-S10 |
artikel |
5 |
Effect of Tween-80 on cell killing by etoposide in human lung adenocarcinoma cells
|
Tsujino, Ichiro |
|
1999 |
43 |
1 |
p. 29-34 |
artikel |
6 |
Effects of SCH 59228, an orally bioavailable farnesyl protein transferase inhibitor, on the growth of oncogene-transformed fibroblasts and a human colon carcinoma xenograft in nude mice
|
Liu, Ming |
|
1999 |
43 |
1 |
p. 50-58 |
artikel |
7 |
Epirubicin-containing high-dose chemotherapy followed by autologous hematopoietic progenitor cell transfusion for patients with chemotherapy-sensitive metastatic breast cancer: results of 5-year follow-up
|
Ito, Yoshinori |
|
1999 |
43 |
1 |
p. 8-12 |
artikel |
8 |
Heterogeneity of multiorgan metastases of human lung cancer cells genetically engineered to produce cytokines and reversal using chimeric monoclonal antibodies in natural killer cell-depleted severe combined immunodeficient mice
|
Sone, Saburo |
|
1999 |
43 |
1 |
p. S26-S31 |
artikel |
9 |
Inability to escalate vinorelbine dose intensity using a daily × 3 schedule with and without filgrastim in patients with metastatic breast cancer
|
Havlin, Kathleen A. |
|
1999 |
43 |
1 |
p. 68-72 |
artikel |
10 |
Inhibition of paclitaxel elimination in the isolated perfused rat liver by Cremophor EL
|
Ellis, A. G. |
|
1999 |
43 |
1 |
p. 13-18 |
artikel |
11 |
In vitro translation of a 2.3-kb splicing variant of the hamster pgp1 gene whose presence in transfectants is associated with decreased drug resistance
|
Ma, Jian Feng |
|
1999 |
43 |
1 |
p. 19-28 |
artikel |
12 |
In vivo and ex vivo gene therapy strategies to treat tumors using adenovirus gene transfer vectors
|
Crystal, Ronald G. |
|
1999 |
43 |
1 |
p. S90-S99 |
artikel |
13 |
Involvement of VEGF and its receptors in ascites tumor formation
|
Shibuya, Masabumi |
|
1999 |
43 |
1 |
p. S72-S77 |
artikel |
14 |
Marimastat (BB2516): Current status of development
|
Steward, William P. |
|
1999 |
43 |
1 |
p. S56-S60 |
artikel |
15 |
Matrilysin as a target for chemotherapy for colon cancer: use of antisense oligonucleotides as antimetastatic agents
|
Miyazaki, Kaoru |
|
1999 |
43 |
1 |
p. S52-S55 |
artikel |
16 |
Matrix metalloproteinases and metastasis
|
Kleiner, David E. |
|
1999 |
43 |
1 |
p. S42-S51 |
artikel |
17 |
Modulation of cyclophosphamide activity by O 6-alkylguanine-DNA alkyltransferase
|
Friedman, Henry S. |
|
1999 |
43 |
1 |
p. 80-85 |
artikel |
18 |
Molecular diagnostic detection of free cancer cells in the peritoneal cavity of patients with gastrointestinal and gynecologic malignancies
|
Nakanishi, Hayao |
|
1999 |
43 |
1 |
p. S32-S36 |
artikel |
19 |
Multiple DNA repair mechanisms and alkylator resistance in the human medulloblastoma cell line D-283 Med (4-HCR)
|
Dong, Qing |
|
1999 |
43 |
1 |
p. 73-79 |
artikel |
20 |
Pharmacokinetics of melphalan in isolated limb perfusion
|
Norda, A. |
|
1999 |
43 |
1 |
p. 35-42 |
artikel |
21 |
Pharmacokinetics of paclitaxel in an anephric patient
|
Woo, Michael H. |
|
1999 |
43 |
1 |
p. 92-96 |
artikel |
22 |
Phase II study of mitoxantrone by 14-day continuous infusion with granulocyte colony-stimulating factor (GCSF) support in patients with metastatic breast cancer and limited prior therapy
|
Pusztai, Lajos |
|
1999 |
43 |
1 |
p. 86-91 |
artikel |
23 |
Preface
|
Saito, Hidehiko |
|
1999 |
43 |
1 |
p. S1-S2 |
artikel |
24 |
Promising new developments in cancer chemotherapy
|
Ferrante, Karen |
|
1999 |
43 |
1 |
p. S61-S68 |
artikel |
25 |
Regulatory issues in the evaluation of antimetastatic and other novel anticancer therapies
|
Friedman, Michael A. |
|
1999 |
43 |
1 |
p. S100-S103 |
artikel |
26 |
Role of radiosurgery in the management of central nervous system metastases
|
Loeffler, Jay S. |
|
1999 |
43 |
1 |
p. S11-S14 |
artikel |
27 |
SCID-hu mice for the study of human cancer metastasis
|
Namikawa, Reiko |
|
1999 |
43 |
1 |
p. S37-S41 |
artikel |
28 |
Successful management of microscopic residual disease in large bowel cancer
|
Sugarbaker, Paul H. |
|
1999 |
43 |
1 |
p. S15-S25 |
artikel |
29 |
Thalidomide up-regulates prostate-specific antigen secretion from LNCaP cells
|
Dixon, Shannon C. |
|
1999 |
43 |
1 |
p. S78-S84 |
artikel |
30 |
The p53 tumor suppressor gene in anticancer agent-induced apoptosis and chemosensitivity of human gastrointestinal cancer cell lines
|
Yamamoto, Manabu |
|
1999 |
43 |
1 |
p. 43-49 |
artikel |
31 |
Use of V79 cells with stably transfected cytochrome P450 cDNAs in studying the metabolism and effects of cytotoxic drugs
|
Philip, Philip Agop |
|
1999 |
43 |
1 |
p. 59-67 |
artikel |